Literature DB >> 11802343

Injectable fillers for facial soft tissue enhancement.

A P Sclafani1, T Romo.   

Abstract

Soft tissue augmentation materials have been advocated for correction of post-surgical or post-traumatic facial defects, as well as for age-related folds and wrinkles. While autogenous tissues may be the safest option, they require a second operative site. Animal-derived or synthetic materials have been advocated since the late 19th century, and have waxed and waned in popularity. In recent years, we have gained a better understanding of the physical events that occur when material is placed within or below the skin. With this knowledge, we stand at the threshold of a new era, where soft tissue fillers can be designed and customized to suit the individual patient. This article will review the major materials that have been or are now advocated for use as soft tissue fillers, and will detail their relative strengths and weaknesses in order to give the clinician a better perspective when considering a material for soft tissue augmentation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11802343     DOI: 10.1055/s-2000-7323

Source DB:  PubMed          Journal:  Facial Plast Surg        ISSN: 0736-6825            Impact factor:   1.446


  4 in total

Review 1.  [Anti-aging. Facts and visions].

Authors:  N Y Schürer
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

2.  A novel hydrogel crosslinked hyaluronan with glycol chitosan.

Authors:  Wei Wang
Journal:  J Mater Sci Mater Med       Date:  2006-12       Impact factor: 3.896

3.  Evaluation of Paste-Type Micronized Acellular Dermal Matrix for Soft Tissue Augmentation: Volumetric and Histological Assessment in a Mouse Model.

Authors:  Lan Sook Chang; Seung Hwan Kim; Hyunsung Kim; Soorack Ryu; Young Bin Choy; Sang Wha Kim
Journal:  Aesthetic Plast Surg       Date:  2022-08-30       Impact factor: 2.708

Review 4.  [Aesthetic dermatology. Botulinumtoxin A and soft tissue augmentation].

Authors:  L Rauch; T Ruzicka
Journal:  Hautarzt       Date:  2004-07       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.